These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2017314)

  • 1. [The treatment of gastrointestinal infections with ciprofloxacin].
    Ippolito A; La Gioia G; Matarrese M; Resta F; Angelini P; Ruffo F
    Minerva Med; 1991 Apr; 82(4):181-7. PubMed ID: 2017314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ciprofloxacin in the treatment of respiratory infections].
    Poggi F; Tognazzi F; Doddi M; Lauri A; Placidi C
    Clin Ter; 1990 Jul; 134(2):111-7. PubMed ID: 2147611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of ciprofloxacin in bacterial infections of the respiratory and gastrointestinal tract].
    Sforza E; De Gennaro M; Ruggieri A; Ninno D; Pastore G
    Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):533-7. PubMed ID: 3274737
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F; Torroba L; Buzón L; Martínez-Beltrán J; Loza E; Baquero F
    Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ciprofloxacin in bacterial infections].
    Belovezhdov N; Monova D
    Vutr Boles; 1989; 28(5):20-4. PubMed ID: 2618005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Simmons JF; Cowley CE; Dozier DB; Galdini AM; Manes MR; Nungester GH; Schreeder MT; Strother KD; Chun BW
    Ala Med; 1989 Feb; 58(8):10-3. PubMed ID: 2646874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ciprofloxacin for treatment of severe infections.
    Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
    Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Chevis SA; Oakes WT
    J Miss State Med Assoc; 1989 May; 30(5):145-8. PubMed ID: 2657076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroral ciprofloxacin in the therapy of infections in oncology patients].
    Krcméry V; Horníková M; Koza I; Fuchsberger P; Spánik S; Sufliarsky J; Mardiak J; Sitáni L; Milosovic P
    Cas Lek Cesk; 1990 Oct; 129(42):1337-8. PubMed ID: 2257584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Hays DJ; Fielder RL; O'Neal ET; Wright AC
    J Ky Med Assoc; 1989 Oct; 87(10):506-9. PubMed ID: 2681482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with ciprofloxacin.
    Palmer JP; Barit MC; Powderly B; Velasquez BG
    W V Med J; 1989 Jul; 85(7):280-2. PubMed ID: 2667259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Hines CH; Bordelon JY; Jens DK; Le CV; McManus LJ; Spurlock WM
    J La State Med Soc; 1989 Dec; 141(12):39-42. PubMed ID: 2691593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with ciprofloxacin.
    Hann JR; Sudderth BF; Baker RV; Harrison RE
    J Ark Med Soc; 1989 Sep; 86(4):156-8. PubMed ID: 2529246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.